Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Immuneering Corp shares valued at $1,160,181 were sold by Cormorant Asset Management, LP on Apr 01 ’24. At $2.90 per share, Cormorant Asset Management, LP sold 400,000 shares. The insider’s holdings dropped to 2,895,273 shares worth approximately $5.7 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Schall Thomas J. purchased 2,900 shares, netting a total of over 7,385 in proceeds. Following the buying of shares at $2.55 each, the insider now holds 2,900 shares.
Before that, Feinberg Peter had added 25,000 shares to its account. In a trade valued at $63,713, the Director bought Immuneering Corp shares for $2.55 each. Upon closing the transaction, the insider’s holdings increased to 25,000 shares, worth approximately $0.22 million.
As published in a research note from Needham on March 15, 2024, Immuneering Corp [IMRX] has been retained to a Buy and the price target has been revised to $15. Analysts at TD Cowen downgraded the stock from ‘”an Outperform”‘ to ‘”a Market perform”‘ outlook in a report released in mid March. As of March 15, 2024, Jefferies has decreased its “Buy” rating to a “Hold” for IMRX. Earlier on December 01, 2023, Needham initiated its rating. Their recommendation was “a Buy” for IMRX stock.
Analyzing IMRX Stock Performance
During the last five days, there has been a drop of approximately -7.94%. Over the course of the year, Immuneering Corp shares have dropped approximately -73.20%. Shares of the company reached a 52-week high of $7.68 on 03/04/24 and a 52-week low of $1.00 on 08/16/24. A 50-day SMA is recorded $2.08, while a 200-day SMA reached $1.98. Nevertheless, trading volume fell to 8.03 million shares from 0.11 million shares the previous day.
Support And Resistance Levels for Immuneering Corp (IMRX)
According to the 24-hour chart, there is a support level at 1.85, which, if violated, would cause prices to drop to 1.74. In the upper region, resistance lies at 2.19. The next price resistance is at 2.42. RSI (Relative Strength Index) is 44.91 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.03, which suggests the price will decrease in the coming days. Percent R is at 97.37%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
